Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC

ABSTRACT: Multiple myeloma (MM) remains an incurable malignancy despite the recent advancements in its treatment. The protective effects of the niche in which it develops has been well documented; however, little has been done to investigate the MM cell’s ability to ‘re-program’ cells within its env...

Descripción completa

Detalles Bibliográficos
Autores principales: Piddock, Rachel E., Marlein, Christopher R., Abdul-Aziz, Amina, Shafat, Manar S., Auger, Martin J., Bowles, Kristian M., Rushworth, Stuart A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956761/
https://www.ncbi.nlm.nih.gov/pubmed/29769142
http://dx.doi.org/10.1186/s13045-018-0614-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956761/
https://www.ncbi.nlm.nih.gov/pubmed/29769142
http://dx.doi.org/10.1186/s13045-018-0614-4

Ejemplares similares